GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » Cyclically Adjusted Price-to-FCF

Daiichinkyo Co (TSE:4568) Cyclically Adjusted Price-to-FCF : 91.20 (As of Jun. 07, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-07), Daiichinkyo Co's current share price is 円5773.00. Daiichinkyo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was 円63.30. Daiichinkyo Co's Cyclically Adjusted Price-to-FCF for today is 91.20.

The historical rank and industry rank for Daiichinkyo Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSE:4568' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 21.98   Med: 68.16   Max: 135.66
Current: 88.13

During the past years, Daiichinkyo Co's highest Cyclically Adjusted Price-to-FCF was 135.66. The lowest was 21.98. And the median was 68.16.

TSE:4568's Cyclically Adjusted Price-to-FCF is ranked worse than
81.37% of 322 companies
in the Drug Manufacturers industry
Industry Median: 32.255 vs TSE:4568: 88.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Daiichinkyo Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was 円-9.073. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is 円63.30 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Daiichinkyo Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Daiichinkyo Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Cyclically Adjusted Price-to-FCF Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.80 85.82 71.59 129.52 75.19

Daiichinkyo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.52 135.65 118.85 58.35 75.19

Competitive Comparison of Daiichinkyo Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Cyclically Adjusted Price-to-FCF falls into.



Daiichinkyo Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Daiichinkyo Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=5773.00/63.3
=91.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichinkyo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Daiichinkyo Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-9.073/107.2000*107.2000
=-9.073

Current CPI (Mar. 2024) = 107.2000.

Daiichinkyo Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 2.209 98.000 2.416
201409 6.434 98.500 7.002
201412 9.779 97.900 10.708
201503 4.328 97.900 4.739
201506 -3.928 98.400 -4.279
201509 12.375 98.500 13.468
201512 8.179 98.100 8.938
201603 31.012 97.900 33.958
201606 12.651 98.100 13.825
201609 11.058 98.000 12.096
201612 -2.706 98.400 -2.948
201703 20.179 98.100 22.051
201706 -4.948 98.500 -5.385
201709 6.415 98.800 6.960
201712 7.675 99.400 8.277
201803 26.619 99.200 28.766
201806 -12.415 99.200 -13.416
201809 3.144 99.900 3.374
201812 2.125 99.700 2.285
201903 20.196 99.700 21.715
201906 32.879 99.800 35.317
201909 6.742 100.100 7.220
201912 10.849 100.500 11.572
202003 23.479 100.300 25.094
202006 8.667 99.900 9.300
202009 24.812 99.900 26.625
202012 6.613 99.300 7.139
202103 25.964 99.900 27.861
202106 -27.463 99.500 -29.588
202109 22.155 100.100 23.726
202112 26.810 100.100 28.712
202203 11.097 101.100 11.767
202206 -21.238 101.800 -22.365
202209 28.063 103.100 29.179
202212 9.614 104.100 9.900
202303 8.135 104.400 8.353
202306 -37.915 105.200 -38.636
202309 -21.311 106.200 -21.512
202312 316.630 106.800 317.816
202403 -9.073 107.200 -9.073

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Daiichinkyo Co  (TSE:4568) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Daiichinkyo Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co (TSE:4568) Business Description

Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (TSE:4568) Headlines

No Headlines